Value and Reverse Total Shoulder Arthroplasty: The Foundation for Orthopaedic Research and Education Perspective

 

Preop

Postop

p value

VAS pain

6.56

1.25

<0.001

ASES pain

19

44

<0.001

ASES function

20

34

<0.001

ASES total

40

79

<0.001

SF-36v2 PF

34

39

0.001

SF-36v2 RP

24

41

<0.001

SF-36v2 BP

35

47

<0.001

SF-36v2 GH

49

46

0.066

SF-36v2 PCS

34

42

<0.001

SF-36v2 VT

45

46

0.183

SF-36v2 SF

42

48

<0.001

SF36v2 RE

35

44

0.006

SF36v2 MH

44

49

0.001

SF36v2 MCS

46

49

0.149

OOSS

42

25

<0.001

Patient satisfaction
 
9
 

VAS visual analogue scale; ASES American Shoulder and Elbow Surgeons score; SF36v2 Short Form-36 version 2; PF physical functioning; RP role-physical; BP bodily pain; GH general health; PCS physical component summary; VT vitality; SF social functioning; RE role-emotional; MH mental health; MCS mental component summary; OOSS objective outcome summary score

Bold: findings were statically significant



The average total 4-year cost of RSA for the patients in this study was $24,661 (standard deviation [SD] $2527; range $19,858–$31,909), and these costs were stratified into the various subgroups based on the timing and nature of the cost. Goods and services provided by the hospital cost an average $20,451 (SD $2569; range $15,783–$27,859), whereas goods and services not provided by the hospital cost $4209 (SD $169; range $3705–$4562).

The prehospitalization, hospitalization, and posthospitalization periods accounted for 2.5, 91.6, and 5.8 % of the 4-year total cost of RSA, respectively. Within the prehospitalization period (Fig. 46.1), the shoulder CT was the most expensive component of care (34 % of prehospitalization cost). During the hospitalization period (Fig. 46.2) and also during the entire 4-year study period, the operating room was the most expensive area (86 % of hospitalization cost and 79 % of total cost). Within the operating room, the implants were the single most expensive component of care (59 % of hospitalization cost and 54 % of total cost). The surgeon’s fee was $1467 and was responsible for 6 % of total cost. In the posthospitalization period (Fig. 46.3), the home health care was the most expensive component of care (70 % of posthospitalization cost).

A321433_1_En_46_Fig1_HTML.gif


Fig. 46.1
RSA cost of various aspects of care during the prehospitalization period. Costs are represented as [mean ± standard deviation; range] with the number of patients that the cost was attributed to in parenthesis. Costs provided by the hospital are in normal font, while non-hospital costs are in italics


A321433_1_En_46_Fig2_HTML.gif


Fig. 46.2
RSA cost of various aspects of care during the hospitalization period. Costs are represented as [mean ± standard deviation; range] with the number of patients that the cost was attributed to in parenthesis. Costs provided by the hospital are in normal font, while non-hospital costs are in italics


A321433_1_En_46_Fig3_HTML.gif


Fig. 46.3
RSA cost of various aspects of care during the posthospitalization period. Costs are represented as [mean ± standard deviation; range] with the number of patients that the cost was attributed to in parenthesis. Costs for the posthospitalization period were outside the hospital system and are in italics

The cost of the six patients, which had major complications, included three patients with infection (the total cost of treatment ranged from $7192 to $34,230), two patients with postoperative fractures treated non-operatively (negligible costs), and one patient who required readmission for COPD exacerbation (hospital cost totaled $7434).



Outcomes and Cost of Reverse Shoulder Arthroplasty in Morbidly Obese, a Case–Control Study [35]


The rising number of morbidly obese patients may have significant consequences on the healthcare system, potentially altering the effectiveness, safety, and cost of certain surgical procedures, including reverse shoulder arthroplasty (RSA). We investigated the effect of morbid obesity on outcomes, complications, disposition, and cost in morbidly obese RSA patients in a 1:3 case–control series.

Our joint registry was searched for all primary RSA patients (excluding fractures) with a minimum of 24-months follow-up from 2003–2010; 21 patients with body mass index (BMI) >40 were identified (follow-up 45 ± 16 months, 17 females/4 males, age 69 ± 7) and compared to 63 matched control patients with BMI <30 (follow-up 48 ± 20 months, 50 females/13 males, age 71 ± 6) after a sample size analysis. Outcome data were obtained pre- and postoperatively. Patients’ Charlson-Deyo comorbidity index (CDI), total comorbidities, operative time, blood loss (EBL), hospitalization length, disposition, cost, and complications were recorded.

There were significant (p < 0.05 for all) and comparable improvements for non-obese and morbidly obese patients in functional outcomes (Table 46.2) and range of motion (Table 46.3).


Table 46.2
Subjective outcome scores of obese versus control patients






























































































































 
Obese

Control

p value

Normally distributed

Obese

Control

VAS pain preop

6.6 ± 1.9

6.2 ± 2.2

0.398

N

N

VAS pain postop

2.2 ± 2.9

1.3 ± 2.2

0.293

N

N

VAS function preop

2.1 ± 2.1

3.6 ± 2.4

0.007

N

N

VAS function postop

6.9 ± 2.4

7.8 ± 2.2

0.090

Y

N

Δ VAS function

4.8 ± 2.4

4.2 ± 2.8

0.345

Y

Y

Satisfaction

8.9 ± 1.6

9.3 ± 1.3

0.280

N

N

SST preop

1.1 ± 1.1

2.1 ± 1.9

0.031

N

N

SST postop

7.0 ± 3.4

8.2 ± 2.9

0.139

Y

N

Δ SST

5.6 ± 3.3

6.1 ± 3.2

0.530

Y

N

ASES pain preop

17.1 ± 9.7

19.3 ± 11.0

0.372

N

N

ASES pain postop

38.8 ± 14.7

43.3 ± 11.0

0.293

N

N

ASES function preop

14.8 ± 10.2

20.5 ± 10.2

0.026

Y

Y

ASES function postop

31.4 ± 9.1

34.9 ± 11.1

0.089

Y

N

Δ ASES function

16.6 ± 12.7

14.4 ± 15.1

0.051

Y

Y

ASES total preop

32.0 ± 12.8

39.9 ± 17.8

0.065

Y

Y

ASES total postop

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Oct 22, 2016 | Posted by in ORTHOPEDIC | Comments Off on Value and Reverse Total Shoulder Arthroplasty: The Foundation for Orthopaedic Research and Education Perspective

Full access? Get Clinical Tree

Get Clinical Tree app for offline access